top of page
pexels-jopwell-2422293.jpg

Matthew Growdon, MD, MPH is a geriatrician and Assistant Professor of Medicine in the University of California, San Francisco (UCSF) Division of Geriatrics. Dr. Growdon’s research is focused on improving the quality and safety of prescribing for older adults. Dr. Growdon received his medical school training at Harvard Medical School and his MPH with an emphasis on quantitative methods from Harvard School of Public Health. He completed residency in internal medicine and primary care at Brigham and Women’s Hospital. He subsequently completed a clinical geriatrics fellowship in the Harvard Medical School Multicampus Geriatric Medicine Fellowship, a chief residency in internal medicine at Brigham and Women’s Hospital, and the Advanced Training in Clinical Research Certificate Program at UCSF. Currently, his research is primarily supported by a NIA Beeson K76, through which he is developing a clinical decision framework for optimizing medication use among older adults with cognitive impairment, with an emphasis on those who live alone. Dr. Growdon's mixed-methods work involves the use of large quantitative datasets including Medicare claims, national survey data, and real-world EHR data as well as qualitative methods and implementation science.


Learning Objectives:

1. Describe high-risk medication use and medication management challenges among older adults who live alone with cognitive impairment.

2. Describe perspectives and experiences of older adults who live alone with cognitive impairment regarding medication management.


"High-Risk Medication Use Among Older Adults Living Alone with Cognitive Impairment"

Dr. Matthew Growdon Assistant Professor, UCSF

October 9, 2025 | 1:00-2:00 P.M. MST




Saul Blecker, MD, MHS is an Associate Professor of Population Health and Medicine at NYU Grossman School of Medicine. He is a general internal medicine physician and researcher focused on improving the quality of care and outcomes for patients with chronic disease. In his research, Dr. Blecker uses electronic health record (EHR) and other large clinical datasets to understand gaps in evidence-based care delivery. He utilizes findings from this data-driven work to guide the development and implementation of electronic tools to improve patient care. Additionally, he uses a combination of advanced analytics, implementation science and practice redesign to address patient adherence to evidence-based therapies.


“Medication Adherence in Hypertension: A Cluster Randomized Clinical Trial”

Presentation by and discussion with first author Saul Blecker, MD, MHS

Thursday, September 25, 2025, 12:00 – 1:00PM ET



Sep 18, 2025 11:00 AM MST

The ASU Roybal Center funds NIH Stage 0–IV behavioral trials focused on developing and testing technology-enabled lifestyle interventions for older adults living alone with cognitive decline. Funded trials apply a mechanism of behavior change (MoBC) approach to identify and test the specific processes or pathways through which interventions are expected influence behavior. This webinar will provide an overview of the Center’s funding priorities and offer guidance on preparing proposals and designing trials that align with the Center’s mission and scope.



bottom of page